
|Articles|August 10, 2020
Efficacy and safety of intravitreal aflibercept (Eylea®) therapy using a proactive treat-and-extend regimen in neovascular AMD
Advertisement
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
Pipeline update: Catch up on recent updates in the retina pipeline
2
Geographic Atrophy in AMD and nAMD Patients: Real-World Management Challenges and Strategies
3
AAO 2025: The safety and efficacy of oral gildeuretinol in participants with intermediate-stage Stargardt disease
4













































